Fuz mRNA level was found downregulated in head-neck squamous cell carcinoma (HNSC) and lung adenocarcinoma (LUAD) tumor samples, and such downregulation contributes to a reduction of the overall survival probabilities in patients. Here, FUZ is linked to head and neck squamous cell carcinoma.